NCT07734870Phase 2Recruiting
Tirzepatide for Treatment of CCCA
In the register
This trial is not attached to a programme in the register yet. Unattached trials are kept on purpose: they are where new programmes turn up first.
What the registry records
- Status
- Recruiting
- Declared phase
- Phase 2
- Sponsor
- Johns Hopkins University
- Participants (registry)
- 20
- Start
- September 2026
- Primary completion
- May 2028 (planned)
- Study completion
- May 2028 (planned)
- Last registry update
- September 2026
- Countries
- United States
Conditions studied: Central Centrifugal Cicatricial Alopecia (CCCA)
Interventions: Tirzepatide, Mounjaro, Zepbound, LY3298176
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.